These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33109690)

  • 1. TMEM16A/ANO1 calcium-activated chloride channel as a novel target for the treatment of human respiratory syncytial virus infection.
    Pearson H; Todd EJAA; Ahrends M; Hover SE; Whitehouse A; Stacey M; Lippiat JD; Wilkens L; Fieguth HG; Danov O; Hesse C; Barr JN; Mankouri J
    Thorax; 2021 Jan; 76(1):64-72. PubMed ID: 33109690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of Fcγ receptors to human respiratory syncytial virus pathogenesis and the impairment of T-cell activation by dendritic cells.
    Gómez RS; Ramirez BA; Céspedes PF; Cautivo KM; Riquelme SA; Prado CE; González PA; Kalergis AM
    Immunology; 2016 Jan; 147(1):55-72. PubMed ID: 26451966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Respiratory Syncytial Virus: Role of Innate Immunity in Clearance and Disease Progression.
    Farrag MA; Almajhdi FN
    Viral Immunol; 2016; 29(1):11-26. PubMed ID: 26679242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice.
    Céspedes PF; Rey-Jurado E; Espinoza JA; Rivera CA; Canedo-Marroquín G; Bueno SM; Kalergis AM
    Vaccine; 2017 Feb; 35(5):757-766. PubMed ID: 28065474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of Host Immunity by Human Respiratory Syncytial Virus Virulence Factors: A Synergic Inhibition of Both Innate and Adaptive Immunity.
    Canedo-Marroquín G; Acevedo-Acevedo O; Rey-Jurado E; Saavedra JM; Lay MK; Bueno SM; Riedel CA; Kalergis AM
    Front Cell Infect Microbiol; 2017; 7():367. PubMed ID: 28861397
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Rijsbergen LC; Rennick LJ; Laksono BM; van Run PRWA; Kuiken T; Duprex WP; de Swart RL; de Vries RD
    J Gen Virol; 2020 Oct; 101(10):1037-1046. PubMed ID: 32692644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liu-He-Tang inhibited plaque formation by human respiratory syncytial virus infection in cell lines of the human respiratory tract.
    Chang JS; Wang KC; Shieh DE; Chiang LC
    J Ethnopharmacol; 2011 Oct; 137(3):1149-55. PubMed ID: 21810459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Jiawei-Yupingfeng-Tang, a Chinese herbal formula, inhibits respiratory viral infections in vitro and in vivo.
    Liu Q; Lu L; Hua M; Xu Y; Xiong H; Hou W; Yang Z
    J Ethnopharmacol; 2013 Nov; 150(2):521-8. PubMed ID: 24051026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Secretome Profiling of a Pediatric Airway Epithelium Infected with hRSV Identified Aberrant Apical/Basolateral Trafficking and Novel Immune Modulating (CXCL6, CXCL16, CSF3) and Antiviral (CEACAM1) Proteins.
    Touzelet O; Broadbent L; Armstrong SD; Aljabr W; Cloutman-Green E; Power UF; Hiscox JA
    Mol Cell Proteomics; 2020 May; 19(5):793-807. PubMed ID: 32075873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Respiratory Syncytial Virus Subgroup A and B Infections in Nasal, Bronchial, Small-Airway, and Organoid-Derived Respiratory Cultures.
    Rijsbergen LC; Lamers MM; Comvalius AD; Koutstaal RW; Schipper D; Duprex WP; Haagmans BL; de Vries RD; de Swart RL
    mSphere; 2021 May; 6(3):. PubMed ID: 33980679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody development for preventing the human respiratory syncytial virus pathology.
    Soto JA; Gálvez NMS; Pacheco GA; Bueno SM; Kalergis AM
    Mol Med; 2020 Apr; 26(1):35. PubMed ID: 32303184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xiao-Qing-Long-Tang (Sho-seiryu-to) inhibited cytopathic effect of human respiratory syncytial virus in cell lines of human respiratory tract.
    Chang JS; Yeh CF; Wang KC; Shieh DE; Yen MH; Chiang LC
    J Ethnopharmacol; 2013 May; 147(2):481-7. PubMed ID: 23542148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Respiratory Syncytial Virus: Infection and Pathology.
    Bohmwald K; Espinoza JA; Rey-Jurado E; Gómez RS; González PA; Bueno SM; Riedel CA; Kalergis AM
    Semin Respir Crit Care Med; 2016 Aug; 37(4):522-37. PubMed ID: 27486734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory damage on respiratory and nervous systems due to hRSV infection.
    Bohmwald K; Espinoza JA; Becerra D; Rivera K; Lay MK; Bueno SM; Riedel CA; Kalergis AM
    Curr Opin Immunol; 2015 Oct; 36():14-21. PubMed ID: 26026788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant subtype A and B human respiratory syncytial virus clinical isolates co-infect the respiratory tract of cotton rats.
    Rennick LJ; Nambulli S; Lemon K; Olinger GY; Crossland NA; Millar EL; Duprex WP
    J Gen Virol; 2020 Oct; 101(10):1056-1068. PubMed ID: 32723429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of human respiratory syncytial virus (HRSV) in children from Ghana with acute lower respiratory tract infection: A molecular epidemiological analysis, 2006 and 2013-2014.
    Obodai E; Odoom JK; Adiku T; Goka B; Wolff T; Biere B; Schweiger B; Reiche J
    PLoS One; 2018; 13(9):e0203788. PubMed ID: 30199549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of a lethal aged mouse model of human respiratory syncytial virus infection.
    Zhang K; Li C; Luo YS; Wen L; Yuan S; Wang D; Ho-Yin Wong B; Zhao X; Chiu MC; Ye ZW; Sun Z; Zhao H; Zhang X; Hu M; Yang D; Shuai H; Wang Y; He J; Bose ME; Henrickson KJ; Huang JD; Zheng B; Chu H; Zhou J
    Antiviral Res; 2019 Jan; 161():125-133. PubMed ID: 30503888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-viral activity of water extract of Paeonia lactiflora pallas against human respiratory syncytial virus in human respiratory tract cell lines.
    Lin TJ; Wang KC; Lin CC; Chiang LC; Chang JS
    Am J Chin Med; 2013; 41(3):585-99. PubMed ID: 23711143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis, Humoral Immune Responses, and Transmission between Cohoused Animals in a Ferret Model of Human Respiratory Syncytial Virus Infection.
    Chan KF; Carolan LA; Druce J; Chappell K; Watterson D; Young P; Korenkov D; Subbarao K; Barr IG; Laurie KL; Reading PC
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29187546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of Fcγ Receptor-Mediated Immunity to the Pathogenesis Caused by the Human Respiratory Syncytial Virus.
    Acevedo OA; Díaz FE; Beals TE; Benavente FM; Soto JA; Escobar-Vera J; González PA; Kalergis AM
    Front Cell Infect Microbiol; 2019; 9():75. PubMed ID: 30984626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.